PHARMACEUTICAL PRODUCTS, NAMELY CONSTANT RELEASE RATE ORAL DOSAGE FORMULATIONS OF THE BETA-ADRENERGIC BLOCKING AGENT PROPRANOLOL HYDROCHLORIDE